Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis

BACKGROUND: 5-Alpha-reductase inhibitors (5-ARIs) have been suggested as potential chemopreventive agents for prostate cancer (PCa). This study was conducted to evaluate the effect of 5-ARIs on the incidence and mortality of PCa. METHODS: The PubMed, Embase and Cochrane Library databases were search...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xu, Wang, Yao-Hui, Yang, Zhi-Qiang, Shao, Yan-Xiang, Yang, Wei-Xiao, Li, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807305/
https://www.ncbi.nlm.nih.gov/pubmed/33457226
http://dx.doi.org/10.21037/tau-20-843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807305/
https://www.ncbi.nlm.nih.gov/pubmed/33457226
http://dx.doi.org/10.21037/tau-20-843

Ejemplares similares